- 米国企業
- Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc.ALRN
時価総額
$1203.4万
PER
2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Cash and cash equivalents | 12 | 11 | 5 | 7 | 4 | 5 |
Investments | 39 | 10 | 13 | 7 | 42 | 16 |
Prepaid expenses and other current assets | 1 | 1 | 1 | 2 | 2 | 1 |
Restricted cash | 0 | 0 | 0 | 1 | 0 | 0 |
Total current assets | 52 | 22 | 20 | 16 | 48 | 22 |
Operating lease, right-of-use asset | - | - | 6 | - | 0 | 0 |
Other non-current assets | 1 | 1 | - | - | 0 | 0 |
Property and equipment, net | 0 | 7 | 0 | 0 | 0 | 0 |
Total assets | 53 | 30 | 26 | 16 | 48 | 22 |
Accounts payable | 2 | 2 | 1 | 2 | 1 | 2 |
Accrued Liabilities and Other Liabilities | 3 | 4 | 4 | 2 | 3 | 2 |
Operating Lease, Liability, Current | - | - | 0 | - | 0 | 0 |
Total current liabilities | 5 | 5 | 6 | 4 | 5 | 3 |
Operating Lease, Liability, Noncurrent | - | - | 5 | - | 0 | - |
Total liabilities | 5 | 11 | 10 | 4 | 5 | 3 |
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 |
Additional paid-in capital | 185 | 188 | 214 | 231 | 289 | 291 |
Accumulated other comprehensive (loss) | -0 | -0 | 0 | -0 | -0 | -0 |
Accumulated deficit | -137 | -168 | -198 | -219 | -245 | -273 |
Total stockholders’ equity | 48 | 20 | 16 | 12 | 44 | 19 |
Total liabilities and stockholders’ equity | 53 | 30 | 26 | 16 | 48 | 22 |